Zai Lab Ltd (ZLAB) is around the top of the Biotechnology industry according to InvestorsObserver. ZLAB received an overall rating of 69, which means that it scores higher than 69 percent of all stocks. Zai Lab Ltd also achieved a score of 73 in the Biotechnology industry, putting it above 73 percent of Biotechnology stocks. Biotechnology is ranked 8 out of the 148 industries.

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as good for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 69 means the stock is more attractive than 69 percent of stocks.

These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

Zai Lab Ltd (ZLAB) stock is down -6.63% while the S&P 500 has risen 0.14% as of 2:18 PM on Friday, May 22. ZLAB is down -$4.49 from the previous closing price of $67.75 on volume of 243,127 shares. Over the past year the S&P 500 is higher by 4.62% while ZLAB has risen 136.22%. ZLAB lost -$3.03 per share the over the last 12 months.

To see the top 5 stocks in Biotechnology click here.

Read more:
Is Zai Lab Ltd (ZLAB) a Winner in the Biotechnology Industry? - InvestorsObserver